ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVBP ArriVent BioPharma Inc

19.89
0.00 (0.00%)
Pre Market
Last Updated: 04:05:26
Delayed by 15 minutes

ArriVent BioPharma Financial Summary

The current AVBP market cap is 635.62M. The company's latest EPS is USD -2.1696 and P/E is -9.17.

Quarter End Dec 2023
USD ($)USD ($)
Total Revenue 0
Operating Income -23.12M
Net Income -21.19M
Year End December 30 2023 20222023
USD ($)USD ($)
Total Revenue 00
Operating Income -36.91M-74.59M
Net Income -36.91M-69.33M
Quarter End Dec 2023
USD ($)USD ($)
Total Assets 163.1M
Total Liabilities 11.8M
Total Equity -153.19M
Year End December 30 2023 20222023
USD ($)USD ($)
Total Assets 182.83M163.1M
Total Liabilities 8.37M11.8M
Total Equity -85.11M-153.19M
Quarter End Dec 2023
USD ($)USD ($)
Operating -55.84M
Investing N/A
Financing 42.86M
Year End December 30 2023 20222023
USD ($)USD ($)
Operating -43.63M-55.84M
Investing N/A N/A
Financing 169.72M42.86M
Market Cap 635.62M
Price to Earnings Ratio -9.17
Price to Sales Ratio 0
Price to Cash Ratio 4.23
Price to Book Ratio 4.2
Dividend Yield -

Share Statistics

Shares Outstanding 31.96M
Average Volume (1 week) 52.62k
Average Volume (1 Month) 50.14k
52 Week Change -17.13%
52 Week High 25.5076
52 Week Low 14.35
Spread (Intraday) 12.1 (52.84%)

Company Info

Company Name ArriVent BioPharma Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://arrivent.com
Industry pharmaceutical preparations (2834)